Home
About
Overview
Sharing Data
ORCID
Help
History (9)
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.
Principal Investigator
Patched-2 Receptor
Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios.
Principal Investigator
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Principal Investigator
Overview
researcher role of
Fox, Aaron
contributes to
Nicotine Addiction: ACh Receptors and Secretion